Literature DB >> 546880

Affinity chromatography on concanavalin A-Sepharose of antigenic fractions of human seminal plasma.

M N Mazzini, A S Cerezo, J M De Cerezo.   

Abstract

Elution diagrams obtained on affinity chromatography show that the antigenic fractions of human seminal plasma studied, namely (a) the non-dialyzable components of human seminal plasma and (b) its trichloroacetic acid-soluble fraction, (c) the trichloroacetic acid-soluble fraction of whole human seminal plasma and (d) the pronase digested human seminal plasma, are complex mixtures of glycoproteins with minor amounts of polysaccharides. Some of these glycoproteins contain significant percentages of carbohydrates while others contain only trace amounts. Most of the glycoproteins carry non-reducing end-chain groups comprising alpha-D-glucopyranosyl, alpha-D-mannopyranosyl or sterically related residues.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 546880     DOI: 10.1016/s0021-9673(00)92305-7

Source DB:  PubMed          Journal:  J Chromatogr


  3 in total

1.  Isolation, partial characterization and biological activity of mannosyl glycopeptides from seminal plasma.

Authors:  C H Lopes; M N Mazzini; H Tortorella; R A Konrath; A Brandelli
Journal:  Glycoconj J       Date:  1998-05       Impact factor: 2.916

2.  Human seminal plasma abrogates the capture and transmission of human immunodeficiency virus type 1 to CD4+ T cells mediated by DC-SIGN.

Authors:  Juan Sabatté; Ana Ceballos; Silvina Raiden; Mónica Vermeulen; Karen Nahmod; Julián Maggini; Gabriela Salamone; Horacio Salomón; Sebastian Amigorena; Jorge Geffner
Journal:  J Virol       Date:  2007-10-03       Impact factor: 5.103

3.  Identification of gp17 glycoprotein and characterization of prostatic acid phosphatase (PAP) and carboxypeptidase E (CPE) fragments in a human seminal plasma fraction interacting with concanavalin A.

Authors:  A C Marquínez; A M Andreetta; N González; C Wolfenstein-Todel; J M Scacciati de Cerezo
Journal:  J Protein Chem       Date:  2003-07
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.